Skip to main content
. 2020 Jul 28;7:436. doi: 10.3389/fmed.2020.00436

Table 5.

Review of the COVID-19 related kidney impairment.

N Pre-existing renal conditions COVID-19-related kidney impairment Notes
Li et al. (10) 59 32/51 exhibited proteinuria, Cre elevated in 11/59, Bun elevated in 16/59; 27/27 exhibited radiographic abnormalities of the kidneys
Cheng et al. (14) 710 22 AKI On admission, sCr elevated in 110/710, 44% have proteinuria hematuria and 26.9% have hematuria; mortality of inpatients with elevated baselines Cr was 30.9%
Yang et al. (17) 52 15 AKI sCr elevated significantly in survivors
Xu et al. (18) 62 1 sCr elevated in 2/62 of time since symptom onset ≤10 days group
Wang et al. (19) 138 4 5 AKI Bun and sCr elevated significantly in ICU group (vs. non-ICU group)
Shi et al. (20) 81 3 CRF
Huang et al. (21) 41 3 AKI sCr elevated in 4/41 (2/41 of ICU group, 2/41 of non-ICU group)
Guan et al. (22) 1,099 8 6 AKI sCr elevated in 12/752 (16/614 of non-severe group, 6/138 of severe group)
Chen et al. (23) 99 3 AKI Bun increased in 6/99, decreased in 17/99; sCr increased in 3/99, decreased in 21/99
Chan et al. (24) 7 Bun elevated in 2/7
Diao et al. (25) 85 5 23 ARF Elder patients (≥60 years old) were easier to develop ARF; perished cases have a rapid decrease of eGFR but quickly boosting ccr and bun; H&E staining: severe acute tubular necrosis; immunohistochemistry: SARS-CoV-2 NP antigen accumulated in kidney tubules.
Our study 116 * 12 AKI sCr elevated in 21/116, 12(10.3%) AKI (5 in-hospital AKI); increasing odds of AKI associated with COVID-19 clinical classification, procalcitonin more than 0.1 ng/mL, and eGFR <60 mL/min/1.73 m2
*

Three patients excluded from the study, as one case receiving regular maintenance dialysis, one diabetic nephropathy, one nephrotic syndrome. AKI, acute kidney injury; ICU, intensive care unit; Bun, blood urea nitrogen; sCr, serum creatinine; Cre, plasma creatinine; CRF, chronic renal failure; ARF, acute renal failure; eGFR, estimated glomerular filtration rate; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; NP, nucleocapsid protein; H&E staining and hematoxylin–eosin staining.